Home > Insider Trading > Filing (0001209191-23-021201)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645460	Cue Biopharma Inc.	CUE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328146	A Peter Kiener	C/O Cue Biopharma Inc. 40 Guest Street Boston MA 02135		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-23	9,682	$2.86	9,682	No	4	M	Direct
Common Stock	Disposition	2023-03-23	9,325	$3.28	357	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2023-03-23	9,682	$0.00	9,682	$2.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
96,062		2023-03-23	No	4	M	Direct

Footnotes

Sale to cover exercise price of cashless exercise of stock option.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
This Stock Option became exercisable in five equal annual installments beginning March 23, 2017 and is fully vested. This stock option expired on March 23, 2023.